Selling Without Shackles: What the FTC's Noncompete Crackdown Means for Your Practice Exit Strategy

For decades, the noncompete clause was the quiet engine of veterinary practice transactions. Sellers relied on it to protect the goodwill they were being paid for. Corporate buyers embedded it in nearly every associate agreement. Young DVMs signed it with a shrug, assuming they would worry about restrictions later.

That era is ending. The Federal Trade Commission's rule banning most noncompete agreements has arrived, and its consequences are rippling through every exam room, buying group, and practice appraisal in the country. At VetPAC, we believe practitioners deserve a clear-eyed account of what this shift means for the largest financial decision most veterinarians will ever make.

Why the Rule Hits Veterinary Medicine Harder Than Most Professions

Veterinary practice sales are unlike dental or medical transactions in one crucial respect: the buyer is frequently purchasing not just equipment and real estate, but the intangible promise that a beloved doctor will not simply reopen across the street. Valuation models — often expressed as a multiple of EBITDA — have long baked in the assumption that covenant restrictions would enforce patient loyalty.

When the FTC eliminated the enforceability of those covenants, buyers lost a contractual guarantee they had been paying for. The immediate question in every transaction room is now simple: how do we price goodwill without it?

The Valuation Question: Goodwill Without a Fence Around It

Three responses are already emerging in the market:

• Earnout structures. Rather than paying a lump sum up front, corporate acquirers increasingly tie a portion of the purchase price to the selling doctor's continued clinical production over three to five years. The money follows the patients — but so does the seller's obligation to keep working.
• Garden-leave and deferred payouts. Some buyers are converting what would have been a noncompete into a paid non-compensation period, effectively purchasing the seller's absence from the local market.
• Tighter non-solicitation language. Restrictions on poaching staff and actively soliciting clients remain largely enforceable and are being drafted with new precision.

Sellers should understand the trade: the headline multiple may look unchanged, but the risk profile of the payout has shifted onto the seller. Read the earnout definitions with a forensic eye — what counts as "production," what happens if the buyer reduces your hours, and what occurs if the corporate owner itself is sold?

Associates and New Graduates: A Different Ledger

For employed veterinarians, the rule is unambiguously good news on its face. The clauses that once chained associates to a five-mile radius — or forced them out of a community entirely after a resignation — are now presumptively void in most jurisdictions.

But vigilance is warranted. Corporate employers are already substituting training repayment agreements, clawback provisions on signing bonuses, and aggressive non-solicitation terms. A clause that requires an associate to repay $40,000 in "education costs" upon departure functions much like a noncompete in practice, and its enforceability under the new federal framework remains unsettled.

The State Board Vacuum

Here is the complication every practitioner should track: the FTC rule does not occupy the entire field. States retain authority over the licensing and practice standards that shape veterinary transactions, and several legislatures are already drafting their own frameworks — some stricter, some offering carve-outs for practice sales.

This creates a fifty-state patchwork at precisely the moment practitioners need clarity. A sale structured in Texas may look materially different from one in California. Veterinary medical associations and state boards will be lobbying hard to fill this vacuum, and the profession's voice in those rooms will determine whether the rules reflect clinical reality or corporate convenience.

A Seller's Practical Playbook

If a practice sale is on your horizon, VetPAC recommends the following before you sign anything:

1. Engage transaction counsel with veterinary-specific experience. Generic business attorneys routinely miss the interplay between state practice-ownership laws and the new federal landscape.
2. Model the earnout. Ask the buyer for historical data on how often their earnout payouts hit full value. If they won't share it, that is your answer.
3. Negotiate the termination triggers. Ensure that a buyer's material breach — reduced staffing, changed formularies, relocation of your practice — releases you from continued obligations.
4. Clarify your post-sale clinical intentions. If you plan to keep practicing, relief work and telehealth carry their own contractual exposure.
5. Talk to your state association. The rules governing your transaction are being written right now, often in committee hearings where no veterinarian is present.

Legacy Beyond the Contract

There is a deeper point beneath the legal machinery. For generations, the noncompete served as a crude proxy for something veterinarians actually wanted: the assurance that the practice they built, and the clients who trusted it, would endure. That assurance cannot ultimately be purchased with restrictive covenants. It is built through mentorship, community trust, and deliberate succession planning.

The end of the noncompete era does not end the obligation to plan your exit thoughtfully. It simply removes the legal scaffolding and leaves the human work — the part that was always the real asset — standing on its own.